UBS Group’s Direxion Daily Pharmaceutical & Medical Bull 2X Shares PILL Stock Holding History

UBS Group’s Portfolio PILL Stock Details PILL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-94,000	Closed	-$2.78M	–	8775
2015 Q3	$2.78M	Buy	+94,000	New	+$3.34M	﹤0.01%	2455

UBS Group's PILL Position: Q4 2015 in Review

UBS Group sold out of Direxion Daily Pharmaceutical & Medical Bull 2X Shares (PILL) in Q4 2015, closing a stake of 94,000 shares — an estimated $2.78M sold.

UBS Group first reported a position in PILL in Q3 2015 and held it in 1 quarter. The position peaked at $2.78M in Q3 2015. 0 funds tracked by Wall St. Rank hold PILL as of Q4 2015.

UBS Group reported no remaining Direxion Daily Pharmaceutical & Medical Bull 2X Shares position as of Q4 2015 after selling out during the quarter.
UBS Group sold 94,000 Direxion Daily Pharmaceutical & Medical Bull 2X Shares shares in Q4 2015, an estimated $2.78M.
UBS Group first reported a position in Direxion Daily Pharmaceutical & Medical Bull 2X Shares in Q3 2015 and held it in 1 quarter.
UBS Group's Direxion Daily Pharmaceutical & Medical Bull 2X Shares position peaked at $2.78M in Q3 2015.
0 funds tracked by Wall St. Rank held Direxion Daily Pharmaceutical & Medical Bull 2X Shares as of Q4 2015.

Based on UBS Group's 13F filing for Q4 2015, filed 16 Feb 2016.